The Microfluidics Cartridge Injection Molding market is projected to grow from $40 billion in 2025 to $75+ billion by 2030, driven by point-of-care diagnostics, single-cell analysis, organ-on-chip platforms, and NGS automation. Learn what's driving this boom, what OEMs need from molding partners, and how TN Plastics supports the next frontier in diagnostics and life sciences.

The point-of-care diagnostic market is projected to reach $85.2 billion by 2035, driven by revolutionary trends in microfluidics, AI integration, and device miniaturization. Discover how injection molding innovation is enabling this transformation and how TN-plastics is positioned to support diagnostic manufacturers navigating emerging technologies, advanced materials, and sustainability requirements shaping the future of healthcare.